BINECT AG (MA10.DE) Fundamental Analysis & Valuation

FRA:MA10 • DE000A3H2135

Current stock price

1.42 EUR
-0.01 (-0.7%)
Last:

This MA10.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. MA10.DE Profitability Analysis

1.1 Basic Checks

  • MA10 had positive earnings in the past year.
  • In the past year MA10 had a positive cash flow from operations.
  • In the past 5 years MA10 has always been profitable.
  • MA10 had a positive operating cash flow in 4 of the past 5 years.
MA10.DE Yearly Net Income VS EBIT VS OCF VS FCFMA10.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

  • MA10 has a Return On Assets (1.35%) which is comparable to the rest of the industry.
  • MA10 has a Return On Equity (1.86%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of MA10 (0.79%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for MA10 is significantly below the industry average of 9.10%.
Industry RankSector Rank
ROA 1.35%
ROE 1.86%
ROIC 0.79%
ROA(3y)0.91%
ROA(5y)1.82%
ROE(3y)1.29%
ROE(5y)2.33%
ROIC(3y)1.66%
ROIC(5y)1.77%
MA10.DE Yearly ROA, ROE, ROICMA10.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • MA10's Profit Margin of 0.72% is in line compared to the rest of the industry. MA10 outperforms 42.50% of its industry peers.
  • In the last couple of years the Profit Margin of MA10 has declined.
  • Looking at the Operating Margin, with a value of 0.48%, MA10 is in line with its industry, outperforming 48.33% of the companies in the same industry.
  • In the last couple of years the Operating Margin of MA10 has declined.
  • With a Gross Margin value of 26.73%, MA10 perfoms like the industry average, outperforming 57.50% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MA10 has declined.
Industry RankSector Rank
OM 0.48%
PM (TTM) 0.72%
GM 26.73%
OM growth 3Y-61.21%
OM growth 5YN/A
PM growth 3Y-25.08%
PM growth 5YN/A
GM growth 3Y-15.4%
GM growth 5Y-15.92%
MA10.DE Yearly Profit, Operating, Gross MarginsMA10.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. MA10.DE Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, MA10 has about the same amount of shares outstanding.
  • The number of shares outstanding for MA10 has been increased compared to 5 years ago.
  • The debt/assets ratio for MA10 has been reduced compared to a year ago.
MA10.DE Yearly Shares OutstandingMA10.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
MA10.DE Yearly Total Debt VS Total AssetsMA10.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • An Altman-Z score of 3.14 indicates that MA10 is not in any danger for bankruptcy at the moment.
  • MA10's Altman-Z score of 3.14 is amongst the best of the industry. MA10 outperforms 80.83% of its industry peers.
  • MA10 has a debt to FCF ratio of 1.80. This is a very positive value and a sign of high solvency as it would only need 1.80 years to pay back of all of its debts.
  • The Debt to FCF ratio of MA10 (1.80) is better than 89.17% of its industry peers.
  • MA10 has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • MA10 has a Debt to Equity ratio of 0.05. This is amongst the best in the industry. MA10 outperforms 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.8
Altman-Z 3.14
ROIC/WACCN/A
WACCN/A
MA10.DE Yearly LT Debt VS Equity VS FCFMA10.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • MA10 has a Current Ratio of 2.30. This indicates that MA10 is financially healthy and has no problem in meeting its short term obligations.
  • MA10 has a better Current ratio (2.30) than 83.33% of its industry peers.
  • MA10 has a Quick Ratio of 2.25. This indicates that MA10 is financially healthy and has no problem in meeting its short term obligations.
  • MA10's Quick ratio of 2.25 is amongst the best of the industry. MA10 outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.3
Quick Ratio 2.25
MA10.DE Yearly Current Assets VS Current LiabilitesMA10.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. MA10.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 160.14% over the past year.
  • Measured over the past years, MA10 shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.66% on average per year.
  • Looking at the last year, MA10 shows a very strong growth in Revenue. The Revenue has grown by 33.76%.
  • Measured over the past years, MA10 shows a quite strong growth in Revenue. The Revenue has been growing by 18.78% on average per year.
EPS 1Y (TTM)160.14%
EPS 3Y-3.66%
EPS 5YN/A
EPS Q2Q%62.08%
Revenue 1Y (TTM)33.76%
Revenue growth 3Y27.54%
Revenue growth 5Y18.78%
Sales Q2Q%19.59%

3.2 Future

  • The Earnings Per Share is expected to grow by 56.29% on average over the next years. This is a very strong growth
  • MA10 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.76% yearly.
EPS Next Y133.33%
EPS Next 2Y73.21%
EPS Next 3Y58.74%
EPS Next 5Y56.29%
Revenue Next Year13.54%
Revenue Next 2Y8.97%
Revenue Next 3Y7.72%
Revenue Next 5Y5.76%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MA10.DE Yearly Revenue VS EstimatesMA10.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5M 10M 15M 20M 25M
MA10.DE Yearly EPS VS EstimatesMA10.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

6

4. MA10.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 28.40, which means the current valuation is very expensive for MA10.
  • The rest of the industry has a similar Price/Earnings ratio as MA10.
  • When comparing the Price/Earnings ratio of MA10 to the average of the S&P500 Index (27.53), we can say MA10 is valued inline with the index average.
  • The Price/Forward Earnings ratio is 15.47, which indicates a correct valuation of MA10.
  • MA10's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MA10 is cheaper than 74.17% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.95, MA10 is valued rather cheaply.
Industry RankSector Rank
PE 28.4
Fwd PE 15.47
MA10.DE Price Earnings VS Forward Price EarningsMA10.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MA10 is valued cheaper than 96.67% of the companies in the same industry.
  • 85.83% of the companies in the same industry are more expensive than MA10, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.01
EV/EBITDA 3.34
MA10.DE Per share dataMA10.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MA10's earnings are expected to grow with 58.74% in the coming years.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y73.21%
EPS Next 3Y58.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MA10.DE Dividend Analysis

5.1 Amount

  • MA10 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MA10.DE Fundamentals: All Metrics, Ratios and Statistics

BINECT AG

FRA:MA10 (4/16/2026, 7:00:00 PM)

1.42

-0.01 (-0.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.57M
Revenue(TTM)22.76M
Net Income(TTM)163.90K
Analysts82.86
Price Target4.03 (183.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 28.4
Fwd PE 15.47
P/S 0.2
P/FCF 14.01
P/OCF 7.07
P/B 0.52
P/tB 1.65
EV/EBITDA 3.34
EPS(TTM)0.05
EY3.52%
EPS(NY)0.09
Fwd EY6.46%
FCF(TTM)0.1
FCFY7.14%
OCF(TTM)0.2
OCFY14.14%
SpS7.07
BVpS2.74
TBVpS0.86
PEG (NY)0.21
PEG (5Y)N/A
Graham Number1.75524 (23.61%)
Profitability
Industry RankSector Rank
ROA 1.35%
ROE 1.86%
ROCE 1.13%
ROIC 0.79%
ROICexc 1.03%
ROICexgc 5.37%
OM 0.48%
PM (TTM) 0.72%
GM 26.73%
FCFM 1.43%
ROA(3y)0.91%
ROA(5y)1.82%
ROE(3y)1.29%
ROE(5y)2.33%
ROIC(3y)1.66%
ROIC(5y)1.77%
ROICexc(3y)2.19%
ROICexc(5y)2.33%
ROICexgc(3y)12.44%
ROICexgc(5y)19.7%
ROCE(3y)2.36%
ROCE(5y)2.52%
ROICexgc growth 3Y-48.71%
ROICexgc growth 5YN/A
ROICexc growth 3Y-52.52%
ROICexc growth 5YN/A
OM growth 3Y-61.21%
OM growth 5YN/A
PM growth 3Y-25.08%
PM growth 5YN/A
GM growth 3Y-15.4%
GM growth 5Y-15.92%
F-Score7
Asset Turnover1.88
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.8
Debt/EBITDA 0.52
Cap/Depr 42.73%
Cap/Sales 1.41%
Interest Coverage 5.21
Cash Conversion 75.23%
Profit Quality 199.09%
Current Ratio 2.3
Quick Ratio 2.25
Altman-Z 3.14
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)157.94%
Cap/Depr(5y)129.01%
Cap/Sales(3y)5.35%
Cap/Sales(5y)4.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)160.14%
EPS 3Y-3.66%
EPS 5YN/A
EPS Q2Q%62.08%
EPS Next Y133.33%
EPS Next 2Y73.21%
EPS Next 3Y58.74%
EPS Next 5Y56.29%
Revenue 1Y (TTM)33.76%
Revenue growth 3Y27.54%
Revenue growth 5Y18.78%
Sales Q2Q%19.59%
Revenue Next Year13.54%
Revenue Next 2Y8.97%
Revenue Next 3Y7.72%
Revenue Next 5Y5.76%
EBIT growth 1Y602.28%
EBIT growth 3Y-50.53%
EBIT growth 5YN/A
EBIT Next Year700%
EBIT Next 3Y122.4%
EBIT Next 5Y84.35%
FCF growth 1Y230.76%
FCF growth 3YN/A
FCF growth 5Y-8.14%
OCF growth 1Y-44.37%
OCF growth 3YN/A
OCF growth 5Y-1.86%

BINECT AG / MA10.DE Fundamental Analysis FAQ

What is the fundamental rating for MA10 stock?

ChartMill assigns a fundamental rating of 6 / 10 to MA10.DE.


What is the valuation status for MA10 stock?

ChartMill assigns a valuation rating of 6 / 10 to BINECT AG (MA10.DE). This can be considered as Fairly Valued.


What is the profitability of MA10 stock?

BINECT AG (MA10.DE) has a profitability rating of 3 / 10.


How financially healthy is BINECT AG?

The financial health rating of BINECT AG (MA10.DE) is 9 / 10.


Can you provide the expected EPS growth for MA10 stock?

The Earnings per Share (EPS) of BINECT AG (MA10.DE) is expected to grow by 133.33% in the next year.